ArticleDiabetology & metabolic syndrome2026
Impact of admission hyperglycemia on clinical outcomes in patients with acute large ischemic stroke undergoing endovascular treatment.
Article in Diabetology & metabolic syndrome, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
backgroundThis study aimed to explore the impact of admission hyperglycemia on clinical outcomes in patients with acute large ischemic stroke undergoing endovascular treatment (EVT).
methodsPatients with admission blood glucose levels were obtained from a prospective cohort study. We defined admission hyperglycemia as blood glucose levels ≥ 7.8 mmol/L. The primary effectiveness outcome was ordinal modified Rankin Scale (mRS) score at 90 days. Secondary effectiveness outcomes included other clinical outcomes (mRS 0-2, mRS 0-3, mRS 0-4) at 90 days. Safety outcomes were mortality at 90 days, and symptomatic intracerebral hemorrhage (sICH) within 48 h.
resultsAmong the 478 patients with recorded admission blood glucose levels, 186 (38.9%) presented with hyperglycemia at admission. Multivariable logistic regression analysis showed a significant inverse association between admission hyperglycemia and the distribution of mRS at 90 days (adjusted odds ratio [aOR], 0.46; 95% CI 0.31-0.67; P < 0.001). Additionally, admission hyperglycemia was significantly associated with increased mortality (aOR, 2.29; 95% CI 1.47-3.57; P < 0.001) and the occurrence of sICH (aOR, 2.08; 95% CI 1.15-3.76; P = 0.015). Restricted cubic spline regression analysis indicated that blood glucose levels exhibited a nonlinear association with sICH, whereas admission hyperglycemia showed a linear relationship with mRS 0-3, mRS 0-2, and mortality.
conclusionsOur results demonstrated that admission hyperglycemia was associated with poor clinical outcomes in patients with acute large ischemic stroke who underwent EVT. This finding suggests that admission hyperglycemia may serve as a valuable prognostic indicator for EVT outcomes and can help inform timely preventive interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.